Literature DB >> 15389283

Expanding role of local anaesthesia in vitreoretinal surgery.

M T J Costen1, R S Newsom, A C Wainwright, A J Luff, C R Canning.   

Abstract

PURPOSE: Local anaesthesia (LA) is increasingly common in vitreoretinal surgery. However, younger patients often have such surgery under general anaesthesia (GA). We reanalysed the anaesthetic practice for vitreoretinal surgery in our unit over a 19-month period.
METHODS: A total of 1003 patients undergoing vitreoretinal surgery between August 2000 and February 2002 were studied. Type of surgery, patient pain score to anaesthesia and surgery, need for sedation and incidence of complications related to the local anaesthetic were recorded. Comparisons were made between this case series and previous data from our unit.
RESULTS: In total, 920/1003 (91.7%) patients had LA. Total operations comprised 418 vitrectomies, 518 retinopexies with or without vitrectomy and 67 buckling procedures. More patients under the age of 35 years had LA than previously (60.2 vs 35.7%, P<0.001). In 920/920 (100%) of cases, LA was administered via intraconal injection, compared to 164/1221 (13.4%) of procedures previously. Significantly more patients under the age of 35 years required sedation (35.9%) than did older patients (19.2%). Overall, use of sedation was significantly increased since our previous study (20.2 vs 7.8%). Anaesthesia and surgery were well tolerated by patients. There were no cases of orbital haemorrhage or ocular perforation. Complications included bradycardia requiring atropine 1/920 (0.1%) and chemosis 88/920 (9.6%).
CONCLUSIONS: LA is well tolerated and effective even in younger patients. Sedation may well be required in younger patients and for procedures involving scleral buckling. The main indication for GA was patient preference. Despite this, such patients accounted for only 5.2% of the total.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15389283     DOI: 10.1038/sj.eye.6701640

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  8 in total

1.  Is day-1 postoperative review necessary after pars plana vitrectomy?

Authors:  P Alexander; L Michaels; R Newsom
Journal:  Eye (Lond)       Date:  2015-08-28       Impact factor: 3.775

2.  Anaesthesia for retinal detachment.

Authors:  A Hunningher; R Hacking
Journal:  BMJ       Date:  2008-06-14

3.  Efficacy and safety of trans-sub-Tenon's retrobulbar anesthesia for pars plana vitrectomy: a randomized trial.

Authors:  Qian Xu; Meiqing Ren; Juanjuan Guan; Guihong Shi; Yan Ni; Jie Luan
Journal:  BMC Ophthalmol       Date:  2022-06-30       Impact factor: 2.086

4.  Comparison of pain experience during 23-G vitreoretinal surgery under topical and retrobulbar anesthesia.

Authors:  Alper Mete; Oguzhan Saygılı; Sabit Kimyon; Can Pamukcu; Seda Çeri; Kıvanç Güngör; Mithat Temizer
Journal:  Int Ophthalmol       Date:  2016-06-22       Impact factor: 2.031

Review 5.  Iatrogenic retinal traumas in ophthalmic surgery.

Authors:  Daniele Tognetto; Maria Teresa di Lauro; Daniela Fanni; Adelia Zagidullina; Luca Michelone; Giuseppe Ravalico
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-07-05       Impact factor: 3.117

6.  Short-term Analysis of the Residual Volume of an Eye Drop Following 23-Gauge Microincision Vitrectomy Surgery.

Authors:  Yong Koo Kang; Jong Chan Im; Jae Pil Shin; In Taek Kim; Dong Ho Park
Journal:  Korean J Ophthalmol       Date:  2017-07-06

7.  Effectiveness of the Heads-Up Surgery System for Retinal Surgery in a Patient with Severe Photophobia.

Authors:  Yuka Saito; Hiroshi Horiguchi; Kei Mizobuchi; Satoshi Katagiri; Hisato Gunji; Tadashi Nakano
Journal:  Int Med Case Rep J       Date:  2021-08-31

8.  COMPARISON OF RETROBULBAR, SUB-TENON ANESTHESIA AND MEDIAL CANTHUS EPISCLERAL ANESTHESIA FOR 25-GAUGE POSTERIOR VITRECTOMY.

Authors:  Derri Roman-Pognuz; Giuseppe Scarpa; Gianni Virgili; Erik Roman-Pognuz; Giacomo Paluzzano; Fabiano Cavarzeran
Journal:  Retina       Date:  2022-01-01       Impact factor: 4.256

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.